Physician
Angeles Ipa, a Medical Corporation
Angeles Ipa, a Medical Corporation was paid $531K by Medicaid between Jan 2018 and Oct 2024, across 239 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 18% of everything it billed.
33Billing provider infoANGELES IPA, A MEDICAL CORPORATION
CYPRESS, CA 90630
CYPRESS, CA 90630
33aNPI1619187978assigned 05/23/2007
33bProvider typeFamily Medicine Physician
28Total paid$531K
24GClaims162,288
24DCodes billed239
24AFirst – last monthJan 2018 – Oct 2024
Compared with peers
Next to other Family Medicine Physician providers in California
Rank by total paid#248 of 2,511
Median peer was paid$13K
This provider vs. median41×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 123,316 | $406K | |
| 2019 | 1,150 | $16K | |
| 2020 | 11,096 | $42K | |
| 2021 | 25,587 | $68K | |
| 2023 | 761 | $0.00 | |
| 2024incomplete | 378 | $0.00 |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 18% | 16,308 | 14,590 | $94K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 14% | 2,877 | 2,699 | $75K |
| 97139 | 5.4% | 973 | 181 | $29K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 4.3% | 739 | 447 | $23K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 4.0% | 3,342 | 3,271 | $21K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 2.9% | 294 | 279 | $16K |
| J3490 | Unclassified drugs | 2.3% | 256 | 203 | $12K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2.3% | 366 | 155 | $12K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 2.3% | 140 | 136 | $12K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 2.2% | 3,299 | 3,228 | $12K |
| 3074F | 2.1% | 2,277 | 2,055 | $11K | |
| 64493 | 1.9% | 62 | 31 | $10K |
227 more codes
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.7% | 965 | $9K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1.5% | 512 | $8K |
| 3008F | 1.5% | 3,681 | $8K | |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | 1.4% | 229 | $8K |
| 64494 | 1.4% | 62 | $7K | |
| 85018 | 1.4% | 2,059 | $7K | |
| 99204 | Doctor's office visit, new patient (more involved) | 1.3% | 120 | $7K |
| 0450 | Emergency room services | 1.1% | 311 | $6K |
| 92551 | 1.1% | 2,487 | $6K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1.1% | 479 | $6K |
| 92081 | 1.1% | 1,768 | $6K | |
| 94760 | 1.0% | 1,317 | $5K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 559 | $5K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 11,720 | $5K |
| 3078F | <1% | 2,219 | $5K | |
| 80053 | Comprehensive metabolic panel | <1% | 9,487 | $5K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 307 | $4K |
| 81002 | <1% | 1,049 | $4K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 2,717 | $4K |
| 36415 | Collection of venous blood by venipuncture | <1% | 6,087 | $3K |
| T1024 | Evaluation and treatment by an integrated, specialty team contracted to provide coordinated care to multiple or severely handicapped children, per encounter | <1% | 99 | $3K |
| 92226 | <1% | 135 | $3K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 117 | $3K |
| 0515 | <1% | 61 | $3K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 271 | $3K |
| 64495 | <1% | 62 | $3K | |
| 99051 | <1% | 129 | $3K | |
| 3079F | <1% | 713 | $3K | |
| 95117 | <1% | 479 | $2K | |
| 99173 | <1% | 871 | $2K | |
| 99223 | Prolong inpt eval add15 m | <1% | 14 | $2K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 26 | $2K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 721 | $2K |
| 99152 | <1% | 14 | $2K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,702 | $2K |
| 86580 | <1% | 348 | $2K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 535 | $2K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 153 | $2K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 86 | $1K |
| 82728 | <1% | 416 | $1K | |
| T4541 | Incontinence product, disposable underpad, large, each | <1% | 24 | $1K |
| 83970 | <1% | 139 | $1K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 6,434 | $1K |
| 80061 | Lipid panel | <1% | 8,213 | $1K |
| 90707 | <1% | 107 | $1K | |
| 90686 | <1% | 120 | $1K | |
| 90700 | <1% | 89 | $980.86 | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 45 | $974.35 |
| 71045 | Radiologic examination, chest; single view | <1% | 132 | $971.27 |
| 81001 | <1% | 2,860 | $970.81 | |
| G0270 | Medical nutrition therapy; reassessment and subsequent intervention(s) following second referral in same year for change in diagnosis, medical condition or treatment regimen (including additional hours needed for renal disease), individual, face to face with the patient, each 15 minutes | <1% | 92 | $962.89 |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 48 | $935.70 |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 366 | $921.32 |
| 90734 | <1% | 187 | $893.76 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 6,213 | $821.27 |
| 92552 | <1% | 271 | $813.62 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 73 | $812.00 |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 41 | $803.15 |
| A0425 | Ground mileage, per statute mile | <1% | 111 | $763.05 |
| 90670 | <1% | 158 | $756.86 | |
| 3075F | <1% | 452 | $717.90 | |
| 97802 | <1% | 410 | $709.38 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 3,098 | $682.11 |
| 83540 | <1% | 441 | $651.21 | |
| 1160F | <1% | 1,432 | $648.49 | |
| 90651 | <1% | 165 | $611.00 | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 61 | $596.89 |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 16 | $595.25 |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 1,589 | $568.91 |
| 90715 | <1% | 113 | $559.67 | |
| 92134 | <1% | 13 | $545.10 | |
| 90680 | <1% | 55 | $511.86 | |
| 90688 | <1% | 130 | $504.27 | |
| 86003 | <1% | 281 | $487.93 | |
| 90658 | <1% | 38 | $474.03 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,953 | $440.38 |
| 81000 | <1% | 286 | $439.15 | |
| 90633 | <1% | 64 | $430.00 | |
| 84460 | <1% | 334 | $419.68 | |
| 90716 | <1% | 101 | $403.00 | |
| 3077F | <1% | 131 | $377.10 | |
| 98941 | Chiropractic manipulative treatment; spinal, 3-4 regions | <1% | 112 | $367.84 |
| 81003 | <1% | 4,102 | $364.74 | |
| A4267 | Contraceptive supply, condom, male, each | <1% | 24 | $359.76 |
| 80076 | <1% | 899 | $355.14 | |
| 82465 | <1% | 150 | $348.87 | |
| 86592 | <1% | 2,387 | $332.83 | |
| 90648 | <1% | 63 | $318.00 | |
| 85027 | <1% | 764 | $314.29 | |
| 83690 | <1% | 223 | $312.43 | |
| 85610 | <1% | 839 | $311.86 | |
| 90657 | <1% | 71 | $310.00 | |
| 1159F | <1% | 1,396 | $291.93 | |
| 3044F | <1% | 94 | $288.30 | |
| 87340 | <1% | 429 | $270.23 | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 93 | $246.46 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 15 | $245.50 |
| 83550 | <1% | 359 | $244.82 | |
| 82962 | <1% | 207 | $239.03 | |
| 86803 | <1% | 266 | $231.98 | |
| 84702 | <1% | 346 | $226.94 | |
| 82310 | <1% | 86 | $219.09 | |
| 81025 | <1% | 128 | $201.01 | |
| 99000 | <1% | 539 | $196.48 | |
| 90713 | <1% | 61 | $173.00 | |
| 80074 | <1% | 328 | $172.52 | |
| 97803 | <1% | 314 | $170.84 | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 163 | $153.61 |
| 82947 | <1% | 811 | $150.84 | |
| 83735 | <1% | 455 | $141.60 | |
| 85730 | <1% | 588 | $141.14 | |
| 87186 | <1% | 616 | $139.22 | |
| 84439 | <1% | 1,803 | $125.20 | |
| 87070 | <1% | 571 | $106.89 | |
| 84295 | <1% | 37 | $101.62 | |
| 86900 | <1% | 274 | $101.61 | |
| 98942 | <1% | 24 | $100.32 | |
| 84153 | <1% | 654 | $94.84 | |
| 99199 | Unlisted special service, procedure or report | <1% | 65 | $91.99 |
| 82570 | <1% | 1,119 | $90.59 | |
| 84100 | <1% | 246 | $89.46 | |
| 84520 | <1% | 58 | $89.28 | |
| 92015 | Determination of refractive state | <1% | 12 | $88.11 |
| 86850 | <1% | 164 | $86.45 | |
| 84450 | <1% | 184 | $84.69 | |
| 83655 | <1% | 701 | $84.61 | |
| 84484 | <1% | 82 | $84.47 | |
| 86706 | <1% | 147 | $78.47 | |
| 90621 | <1% | 25 | $73.00 | |
| 84703 | <1% | 123 | $72.80 | |
| 4004F | <1% | 28 | $70.00 | |
| 98943 | <1% | 36 | $66.88 | |
| 84436 | <1% | 1,578 | $62.96 | |
| 88142 | <1% | 327 | $54.75 | |
| 82043 | <1% | 1,533 | $53.19 | |
| 87088 | <1% | 185 | $50.27 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 44 | $50.00 |
| 84480 | <1% | 550 | $48.72 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 14 | $45.00 |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 219 | $44.08 |
| 82607 | <1% | 262 | $39.99 | |
| 82248 | <1% | 67 | $39.67 | |
| 84550 | <1% | 1,457 | $39.01 | |
| 82652 | <1% | 61 | $33.18 | |
| 83001 | <1% | 161 | $30.96 | |
| 86038 | <1% | 659 | $29.66 | |
| 86140 | <1% | 421 | $29.63 | |
| 87081 | <1% | 362 | $28.73 | |
| 82274 | <1% | 664 | $28.58 | |
| 86901 | <1% | 276 | $28.31 | |
| 82565 | <1% | 173 | $24.77 | |
| 3210F | <1% | 27 | $24.00 | |
| 86704 | <1% | 12 | $23.78 | |
| 86431 | <1% | 620 | $18.95 | |
| 87077 | <1% | 63 | $18.33 | |
| 84479 | <1% | 875 | $16.92 | |
| 84481 | <1% | 115 | $14.82 | |
| 90744 | <1% | 17 | $14.00 | |
| 90649 | <1% | 12 | $14.00 | |
| 82746 | <1% | 111 | $13.25 | |
| 88141 | <1% | 41 | $10.53 | |
| 85652 | <1% | 660 | $9.56 | |
| 83721 | <1% | 42 | $8.14 | |
| 82150 | <1% | 12 | $7.46 | |
| 82247 | <1% | 27 | $6.48 | |
| 85007 | <1% | 32 | $6.16 | |
| 83615 | <1% | 12 | $4.29 | |
| 82950 | <1% | 48 | $4.19 | |
| 85651 | <1% | 140 | $2.35 | |
| 83002 | 0% | 106 | $0.00 | |
| 82550 | 0% | 133 | $0.00 | |
| 86762 | 0% | 141 | $0.00 | |
| 86060 | 0% | 238 | $0.00 | |
| 2001F | 0% | 68 | $0.00 | |
| 86695 | 0% | 65 | $0.00 | |
| 1126F | 0% | 82 | $0.00 | |
| 1000F | 0% | 12 | $0.00 | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 0% | 13 | $0.00 |
| 96156 | 0% | 64 | $0.00 | |
| 2000F | 0% | 68 | $0.00 | |
| 99443 | 0% | 50 | $0.00 | |
| 81005 | 0% | 43 | $0.00 | |
| 87110 | 0% | 27 | $0.00 | |
| 87529 | 0% | 24 | $0.00 | |
| 84154 | 0% | 60 | $0.00 | |
| 99172 | 0% | 48 | $0.00 | |
| 84144 | 0% | 12 | $0.00 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 12 | $0.00 |
| H0049 | Alcohol and/or drug screening | 0% | 15 | $0.00 |
| 86160 | 0% | 13 | $0.00 | |
| 2010F | 0% | 68 | $0.00 | |
| 84132 | 0% | 14 | $0.00 | |
| G8711 | Prescribed antibiotic on or within 3 days after the episode date | 0% | 27 | $0.00 |
| 1170F | 0% | 15 | $0.00 | |
| 86005 | 0% | 12 | $0.00 | |
| 1125F | 0% | 22 | $0.00 | |
| 86376 | 0% | 29 | $0.00 | |
| 93000 | 0% | 12 | $0.00 | |
| 84478 | 0% | 13 | $0.00 | |
| S9449 | Weight management classes, non-physician provider, per session | 0% | 35 | $0.00 |
| 86677 | 0% | 189 | $0.00 | |
| 84403 | 0% | 115 | $0.00 | |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | 0% | 212 | $0.00 |
| 82785 | 0% | 149 | $0.00 | |
| 99442 | 0% | 95 | $0.00 | |
| T1017 | Case management, billed per 15 minutes | 0% | 1,139 | $0.00 |
| 85014 | 0% | 29 | $0.00 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 0% | 27 | $0.00 |
| 84146 | 0% | 52 | $0.00 | |
| G9920 | Screening performed and negative | 0% | 217 | $0.00 |
| 80306 | 0% | 12 | $0.00 | |
| 87177 | 0% | 15 | $0.00 | |
| 86696 | 0% | 84 | $0.00 | |
| 3725F | 0% | 27 | $0.00 | |
| 86703 | 0% | 92 | $0.00 | |
| 87338 | 0% | 70 | $0.00 | |
| 87209 | 0% | 15 | $0.00 | |
| 82948 | 0% | 13 | $0.00 | |
| 90461 | 0% | 27 | $0.00 | |
| H0050 | Alcohol and/or drug services, brief intervention, per 15 minutes | 0% | 13 | $0.00 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 0% | 12 | $0.00 |
| 99401 | 0% | 13 | $0.00 | |
| 86708 | 0% | 12 | $0.00 | |
| 87481 | 0% | 12 | $0.00 | |
| 84155 | 0% | 12 | $0.00 | |
| S9470 | Nutritional counseling, dietitian visit | 0% | 13 | $0.00 |
| 84156 | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialAZURIN, NARCISO (PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Narciso M Azurin MD INC | South Gate, CA | $45K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.